FDA Investigator

Christopher R Czajka

Latest inspection on record: Houston, United States, February 2026 · records back to 2010

Human DrugsFoods & CosmeticsMedical Devices & Rad HealthAnimal Drugs & Feeds

FDA inspection record · Last updated July 12, 2026

Overview

  • 164 inspections across 157 sites are on record.
  • 610 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-02-13.

At a glance

Inspections

164

Sites

157

Observations

610

Career since

Nov 2010

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
The Methodist Hospital Research Institute13 Feb 2026Human DrugsOn file
Cardinal Health 414 LLC23 Jan 2026Human DrugsOn file
PETNET Solutions, Inc.11 Dec 2025Human Drugs
Alliance Medical Products, Inc.7 Nov 2025Human DrugsOn file
Avantor Performance Materials India Limited17 Sep 2025Human DrugsOn file

Sites inspected

The Methodist Hospital Research InstituteHouston, United States1 insp.
Cardinal Health 414 LLCPhoenix, United States1 insp.
PETNET Solutions, Inc.Dallas, United States1 insp.
Alliance Medical Products, Inc.Irvine, United States1 insp.
Avantor Performance Materials India LimitedThane, India1 insp.

Co-investigators

Investigators who share inspections with this person.

Anita Narula6 shared
Gerard P De Leon5 shared
Katherine L Arnold5 shared
Walden H Lee4 shared
Mark W Babbitt4 shared
Vioela J Caze3 shared
Robert D Tollefsen3 shared
Leon R Marquart3 shared

Full investigator report

Get the verbatim findings behind Christopher R Czajka's 610 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators